Citrine Global Corp. (CTGL)
OTCMKTS
· Delayed Price · Currency is USD
0.200
-0.020 (-8.99%)
At close: Dec 5, 2025
Citrine Global Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
246.99M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cordyceps Sunshine Biotech Holdings | 1.25M |
| DFP Holdings | 1.45M |
| Cuisine Solutions | 80.48M |
| Armanino Foods of Distinction | 73.15M |
| Microalliance Group | 22.88M |
| Goldenwell Biotech | 37.34K |
| South Dakota Soybean Processors, LLC | 484.17M |
| ESG Inc. | 10.13M |
Citrine Global News
- 18 days ago - Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (CTGL) announces CEO Ora Elharar Soffer as a UVID 2025 keynote speaker and will showcase the SkyTech Replicator™ modular drone platform and SkyTech Center, Israel's UAV hub - GlobeNewsWire
- 5 weeks ago - Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (OTCQB: CTGL) Participates at AUVSI Defense 2025 Held in Washington, D.C., Launching SkyTech Replicator™, A Revolutionary Modular Drone that Transforms into 4 Different Mission Drones - GlobeNewsWire
- 6 weeks ago - Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (OTCQB: CTGL) today issued a shareholder update letter from the Company's Chairwoman and Chief Executive Officer, Ora Elharar-Soffer - GlobeNewsWire
- 2 years ago - Citrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements' Company with Fast-Growing Potential - GlobeNewsWire
- 3 years ago - Citrine Global Corp. (CTGL) Signs MOU with MyPlant Bio, Specialized in Botanical Drug Development, to Acquire 55% of MyPlant's Shares against Citrine Global Shares - GlobeNewsWire
- 3 years ago - Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects - GlobeNewsWire
- 3 years ago - Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle - GlobeNewsWire
- 3 years ago - Citrine Global Corp. (OTCQB: CTGL) Announces Prof. Itamar Grotto, a World-Renowned Expert in Public Health, Joining the Company's Israeli Subsidiary Board of Directors, and Appointed as President of Green Vision Center Israel - GlobeNewsWire